Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
De Luca
Fabian De Luca, Luedenscheid DE
| Patent application number | Description | Published |
|---|---|---|
| 20120153673 | REAR MOTOR VEHICLE FLOOR MODULE - A rear floor module is arranged between two rear frame rails of a vehicle body running essentially in the longitudinal direction of the vehicle. The floor module includes, but is not limited to a floor tray essentially extending flatly between the frame rails and at least one integrated cross member, which is configured for separately connection with the frame rails for transmitting mechanical forces, and which is provided with a connecting structure to which at least one component of a vehicle chassis can be secured. | 06-21-2012 |
| 20120153674 | REAR MOTOR VEHICLE FLOOR MODULE - A rear floor module arranged between two rear frame rails of a vehicle body running essentially in the longitudinal direction of the vehicle. The floor module includes, but is not limited to a floor tray essentially extending flatly between the frame rails and at least one integrated cross member, whose end sections arranged underneath the frame rails can be separately connected with the frame rails for transmitting mechanical forces. | 06-21-2012 |
Giampiero De Luca, Conches/geneva CH
| Patent application number | Description | Published |
|---|---|---|
| 20100203017 | Cladribine Regimen for Treating Multiple Sclerosis - The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible. | 08-12-2010 |
Giampiero De Luca, Conches CH
| Patent application number | Description | Published |
|---|---|---|
| 20080260690 | Interferon in Influenza - The use of an interferon (IFN) for the manufacture of a medicament for treatment and/or prevention of influenza, preferably avian influenza, is described in the present invention. | 10-23-2008 |
| 20090081163 | CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS - The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be orally administered and wherein re-treatments are possible. | 03-26-2009 |
| 20090130712 | Compositions and Methods of Producing Hybrid Antigen Binding Molecules and Uses Thereof - This disclosure relates to hybrid antigen binding molecules including at least two polypeptide chains, with at least one polypeptide chain comprises an antigen binding moiety linked to an amino acid sequence of a subunit of a heterodimeric proteinaceous hormone. Also disclosed are methods of making and using such hybrid antigen binding molecules for diagnosis and/or therapy. | 05-21-2009 |
| 20100129353 | COMBINATION AND TREATMENT FOR MULTIPLE SCLEROSIS - This invention is directed towards treatments for multiple sclerosis comprising administering to a patient in need thereof a first agent, such as 2-chloro-2′-deoxyadenosine (2-CdA), that reduces the number of lymphocytes in combination with a second agent, such as an anti-alpha-4 integrin antibody, that blocks the adhesion of monocytes and leukocytes to endothelial cells. The use of 2-CdA combined with an anti-alpha-4 integrin antibody may be more effective than either treatment alone for MS. Furthermore, the combination treatment may allow for a lowering or altering the dose of one or more of the agents in order to limit any adverse effects associated with the individual agents, but maintaining the same therapeutic efficacy. | 05-27-2010 |
Jeancarlo De Luca, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20100179173 | SUBSTITUTED FUSED PYRIMIDINES AS ANTAGONISTS OF GPR105 ACTIVITY - Fused pyrimidine compounds of structural formula (I) are effective as antagonists of the biological activity of the GPR105 protein. They are useful for the treatment, control or prevention of disorders responsive to antagonism of this receptor, such as diabetes, particularly, Type 2 diabetes, insulin resistance, hyperglycemia, lipid disorders, obesity, atherosclerosis, and Metabolic Syndrome. | 07-15-2010 |
Riccardo De Luca, Wabern CH
| Patent application number | Description | Published |
|---|---|---|
| 20110050002 | ENERGY SUPPLY SYSTEM WITH A PROTECTED SOLAR MODULE - The energy supply system comprises at least one protected solar module with at least one photovoltaic cell and a local control unit connected to a switching module, which is controllable in such a way that the transfer of electrical energy from the photovoltaic cell via first and second wires of a power line to a load is interruptable in the event that a verification procedure that can be performed by the local control unit has provided a negative result. According to the present invention a chip-card with an electronic module is provided for each or for a plurality of solar modules comprising a first access code that corresponds to a second access code stored in a memory unit, and that a card-reader is provided. | 03-03-2011 |
Rita De Luca, Souvret BE
| Patent application number | Description | Published |
|---|---|---|
| 20110177272 | Heterophasic Propylene Copolymer with Improved Properties for Injection Molding Applications - The present invention concerns a heterophasic propylene copolymer of high melt flow for injection molding, which comprise a propylene polymer matrix and a rubber. The heterophasic propylene copolymers of the present invention are characterized by a high viscosity of the rubber phase and a well-defined ratio of the intrinsic viscosities of the rubber phase and the propylene polymer matrix, thus resulting in improved mechanical properties. The present invention further relates to a process for the production of such heterophasic propylene copolymers, their use and articles produced with them. | 07-21-2011 |